Vapotherm UK Ltd

Vapotherm is a global medical technology company transforming respiratory care with our proprietary high velocity therapy. Designed for patients of all ages, high velocity therapy provides non-invasive ventilatory support for those in respiratory distress from conditions such as asthma, COPD, pneumonia, bronchitis, CHF, dyspnoea, or following prolonged mechanical ventilation.

With the support of progressive health care providers, we’ve treated more than 4.1 million patients suffering from acute respiratory distress, from premature babies to geriatrics.

Our Precision Flow® and HVT 2.0® systems deliver heated, humidified, oxygenated air at high velocity
through a comfortable nasal interface—offering a clinically validated alternative to traditional non-invasive ventilation.

Clinical studies, including randomised controlled trials, have shown high velocity therapy to be a proven, effective alternative that helps clinicians avoid intubation in patients ranging from premature infants in the NICU to adults with acute COPD exacerbations in Emergency and ICU settings.